Skip directly to site content

AR Isolate Bank Citations

The following are peer-reviewed publications that cite the CDC & FDA AR Isolate Bank.

If you have published your work using AR Isolate Bank isolates, we would like to hear about it. Please email us at ARbank@cdc.gov to share the title, publication information, and link or DOI.

References to non-CDC sites on the Internet are provided as a service to the CDC and FDA AR Isolate Bank readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed on this page were current as of the date of publication.

1.
A novel platform to accelerate antimicrobial susceptibility testing in Neisseria gonorrhoeae using RNA signatures
Marjan M. Hashemi, Nikhil Ram-Mohan, Xi Yang, Nadya Andini, Nicholas R. Gessner, Karen C. Carroll, Tza-Huei Wang, Samuel Yang
Journal of Clinical Microbiology Sep 2020, JCM.01152-20; DOI: https://doi.org/10.1128/JCM.01152-20       

2.
Bringing Antimicrobial Susceptibility Testing for New Drugs into the Clinical Laboratory: Removing Obstacles in Our Fight against Multidrug-Resistant Pathogens
James E. Kirby, Thea Brennan-Krohn, Kenneth P. Smith
Journal of Clinical Microbiology Nov 2019, 57 (12) e01270-19; DOI: https://doi.org/10.1128/JCM.01270-19       

3.
Direct Detection of Emergent Fungal Pathogen Candida auris in Clinical Skin Swabs by SYBR Green-Based Quantitative PCR Assay
D. Joseph Sexton, Milena Kordalewska, Meghan L. Bentz, Rory M. Welsh, David S. Perlin, Anastasia P. Litvintseva
Journal of Clinical Microbiology Nov 2018, 56 (12) e01337-18; DOI: https://doi.org/10.1128/JCM.01337-18       

4.
Efficacy of Human-Simulated Epithelial Lining Fluid Exposure of Meropenem-Nacubactam Combination against Class A Serine β-Lactamase-Producing Enterobacteriaceae in the Neutropenic Murine Lung Infection Model
Tomefa E. Asempa, Ana Motos, Kamilia Abdelraouf, Caterina Bissantz, Claudia Zampaloni, David P. Nicolau
Antimicrobial Agents and Chemotherapy Mar 2019, 63 (4) e02382-18; DOI: https://doi.org/10.1128/AAC.02382-18       

5.
Evaluation of Calcium-Enhanced Media for Colistin Susceptibility Testing by Gradient Agar Diffusion and Broth Microdilution
Daniel A. Green, Nenad Macesic, Anne-Catrin Uhlemann, Mabel Lopez, Stephania Stump, Susan Whittier, Audrey N. Schuetz, Patricia J. Simner, Romney M. Humphries
Journal of Clinical Microbiology Jan 2020, 58 (2) e01522-19; DOI: https://doi.org/10.1128/JCM.01522-19       

6.
Evaluation of the NG-Test MCR-1 Lateral Flow Assay and EDTA-Colistin Broth Disk Elution Methods to Detect Plasmid-Mediated Colistin Resistance among Gram-Negative Bacterial Isolates
Alexander J. Fenwick, Yehudit Bergman, Shawna Lewis, Rebecca Yee, Anne-Catrin Uhlemann, Nicolynn Cole, Peggy Kohner, Carly Ordak, Daniel A. Green, Audrey N. Schuetz, Romney Humphries, Patricia J. Simner
Journal of Clinical Microbiology Mar 2020, 58 (4) e01823-19; DOI: https://doi.org/10.1128/JCM.01823-19       

7.
Evaluation of the Rapid Polymyxin NP Test for Polymyxin B Resistance Detection Using Enterobacter cloacae and Enterobacter aerogenes Isolates
Shelby Simar, Diane Sibley, Deborah Ashcraft, George Pankey
Journal of Clinical Microbiology Sep 2017, 55 (10) 3016-3020; DOI: https://doi.org/10.1128/JCM.00934-17       

8.
Exploration of the Neisseria resistome reveals resistance mechanisms in commensals that may be acquired by N. gonorrhoeae through horizontal gene transfer
Michael A. Fiore, Jordan C. Raisman, Narayan H. Wong, André O. Hudson, Crista B. Wadsworth
bioRxiv 2020.07.30.228593; DOI: https://doi.org/10.1101/2020.07.30.228593       

9.
Imipenem-Relebactam Susceptibility Testing of Gram-Negative Bacilli by Agar Dilution, Disk Diffusion, and Gradient Strip Methods Compared with Broth Microdilution
Hanna Hakvoort, Evelyn Bovenkamp, Kerryl E. Greenwood-Quaintance, Suzannah M. Schmidt-Malan, Jay N. Mandrekar, Audrey N. Schuetz, Robin Patel
Journal of Clinical Microbiology Sep 2020, 58 (10) e00695-20; DOI: https://doi.org/10.1128/JCM.00695-20       

10.
Insights into the Unique Nature of the East Asian Clade of the Emerging Pathogenic Yeast Candida auris
Rory M. Welsh, D. Joseph Sexton, Kaitlin Forsberg, Snigdha Vallabhaneni, Anastasia Litvintseva
Journal of Clinical Microbiology Mar 2019, 57 (4) e00007-19; DOI: https://doi.org/10.1128/JCM.00007-19       

11.
Laboratory Analysis of an Outbreak of Candida auris in New York from 2016 to 2018: Impact and Lessons Learned
YanChun Zhu, Brittany O’Brien, Lynn Leach, Alexandra Clarke, Marian Bates, Eleanor Adams, Belinda Ostrowsky, Monica Quinn, Elizabeth Dufort, Karen Southwick, Richard Erazo, Valerie B. Haley, Coralie Bucher, Vishnu Chaturvedi, Ronald J. Limberger, Debra Blog, Emily Lutterloh, Sudha Chaturvedi
Journal of Clinical Microbiology Mar 2020, 58 (4) e01503-19; DOI: https://doi.org/10.1128/JCM.01503-19       

12.
Locus CauMT1 Provides a Higher-Resolution Alternative to Ribosomal Gene Sequencing for Initial Candida auris Genotyping
Santosh Katiyar, Tom Edlind
Journal of Clinical Microbiology Aug 2020, 58 (9) e01039-20; DOI: https://doi.org/10.1128/JCM.01039-20       

13.
Misidentification of Candida auris by RapID Yeast Plus, a Commercial, Biochemical Enzyme-Based Manual Rapid Identification System
Mary Snayd, Feliciano Dias, Raymond W. Ryan, Donna Clout, David B. Banach
Journal of Clinical Microbiology Apr 2018, 56 (5) e00080-18; DOI: https://doi.org/10.1128/JCM.00080-18       

14.
Multicenter Evaluation of Colistin Broth Disk Elution and Colistin Agar Test: a Report from the Clinical and Laboratory Standards Institute
Romney M. Humphries, Daniel A. Green, Audrey N. Schuetz, Yehudit Bergman, Shawna Lewis, Rebecca Yee, Stephania Stump, Mabel Lopez, Nenad Macesic, Anne-Catrin Uhlemann, Peggy Kohner, Nicolynn Cole, Patricia J. Simner
Journal of Clinical Microbiology Oct 2019, 57 (11) e01269-19; DOI: https://doi.org/10.1128/JCM.01269-19       

15.
Paenipeptin Analogues Potentiate Clarithromycin and Rifampin against mcr-1-Mediated Polymyxin-Resistant Escherichia coli In Vivo
Sun Hee Moon, Yihong Kaufmann, En Huang
Antimicrobial Agents and Chemotherapy Mar 2020, 64 (4) e02045-19; DOI: https://doi.org/10.1128/AAC.02045-19       

16.
Performance Evaluation of Culture-Independent SYBR Green Candida auris Quantitative PCR Diagnostics on Anterior Nares Surveillance Swabs
Ourania Georgacopoulos, Natalie S. Nunnally, Ngoc Le, Colleen Lysen, Rory M. Welsh, Milena Kordalewska, David S. Perlin, Elizabeth L. Berkow, D. Joseph Sexton
Journal of Clinical Microbiology Aug 2020, 58 (9) e00690-20; DOI: https://doi.org/10.1128/JCM.00690-20       

17.
Performance of Four Fosfomycin Susceptibility Testing Methods against an International Collection of Clinical Pseudomonas aeruginosa Isolates
Elizabeth C. Smith, Hunter V. Brigman, Jadyn C. Anderson, Christopher L. Emery, Tiffany E. Bias, Phillip J. Bergen, Cornelia B. Landersdorfer, Elizabeth B. Hirsch
Journal of Clinical Microbiology Sep 2020, 58 (10) e01121-20; DOI: https://doi.org/10.1128/JCM.01121-20       

18.
Validation of Aztreonam-Avibactam Susceptibility Testing Using Digitally Dispensed Custom Panels.
Ransom, E., Bhatnagar, A., Patel, J. B., Machado, M. J., Boyd, S., Reese, N., Lutgring, J. D., Lonsway, D., Anderson, K., Brown, A. C., Elkins, C. A., Rasheed, J. K., & Karlsson, M. (2020).
Journal of clinical microbiology, 58(4), e01944-19. https://doi.org/10.1128/JCM.01944-19       

19.
Variability in Zinc Concentration among Mueller-Hinton Broth Brands: Impact on Antimicrobial Susceptibility Testing of Metallo-β-lactamase-producing Enterobacteriaceae
Anastasia Bilinskaya, Douglas J. Buckheit, Michael Gnoinski, Tomefa E. Asempa, David P. Nicolau
Journal of Clinical Microbiology Sep 2020, JCM.02019-20; DOI: https://doi.org/10.1128/JCM.02019-20       

20.
We Cannot Do It Alone: The Intersection of Public Health, Public Policy, and Clinical Microbiology.
Rose A. Lee, James E. Kirby
Clinics in Laboratory Medicine Volume 39, Issue 3, Sep 2019, Pages 499-508; https://doi.org/10.1016/j.cll.2019.05.008       

21.
Micafungin and amphotericin B synergy against Candida auris
Siddharth Jaggavarapu, Eileen M Burd, David S Weiss
The Lancet Microbe, Volume 1, Issue 8, 2020, Pages e314-e315, ISSN 2666-5247; DOI: https://doi.org/10.1016/S2666-5247(20)30194-4       

22.
Efficacy of EBL-1003 (apramycin) against Acinetobacter baumannii lung infections in mice,
Katja Becker, Vincent Aranzana-Climent, Sha Cao, Anna Nilsson, Reza Shariatgorji, Klara Haldimann, Björn Platzack, Diarmaid Hughes, Per E. Andrén, Erik C. Böttger, Lena E. Friberg, Sven N. Hobbie
Clinical Microbiology and Infection, Volume 27, Issue 9, 2021, Pages 1315-1321, ISSN 1198-743X; DOI: https://doi.org/10.1016/j.cmi.2020.12.004       

23.
Synergistic Combinations and Repurposed Antibiotics Active against the Pandrug-Resistant Klebsiella pneumoniae Nevada Strain. Brennan-Krohn T, Kirby JE Antimicrob Agents Chemother.
2019 Aug 23;63(9):e01374-19. DOI: https://doi.org/10.1128/AAC.01374-19       
PMID: 31307981; PMCID: PMC6709503.

24.
A Whole-Cell Screen for Adjunctive and Direct Antimicrobials Active against Carbapenem-Resistant Enterobacteriaceae.
Smith KP, Dowgiallo MG, Chiaraviglio L, Parvatkar P, Kim C, Manetsch R, Kirby JE.
SLAS Discov. 2019 Sep;24(8):842-853. DOI: https://doi.org/10.1177/2472555219859592       
Epub 2019 Jul 3. PMID: 31268804; PMCID: PMC6702050.

25.
Evaluation of apramycin against spectinomycin-resistant and -susceptible strains of Neisseria gonorrhoeae.
Riedel S, Vijayakumar D, Berg G, Kang AD, Smith KP, Kirby JE.
J Antimicrob Chemother. 2019 May 1;74(5):1311-1316. DOI: https://doi.org/10.1093/jac/dkz012       
PMID: 30689929; PMCID: PMC6477976

26.
Synergistic Activity of Colistin- Containing Combinations against Colistin-Resistant Enterobacteriaceae.
Brennan-Krohn T, Pironti A, Kirby JE.
Antimicrob Agents Chemother. 2018 Sep 24;62(10):e00873-18. DOI: https://doi.org/10.1128/AAC.00873-18       
PMID: 30061285; PMCID: PMC6153801.

27.
Evaluation of apramycin activity against methicillin-resistant, methicillin-sensitive, and vancomycin- intermediate Staphylococcus aureus clinical isolates.
Truelson KA, Brennan-Krohn T, Smith KP, Kirby JE.
Diagn Microbiol Infect Dis. 2018 Oct;92(2):168-171. DOI: https://doi.org/10.1016/j.diagmicrobio.2018.05.018       
Epub 2018 May 29. PMID: 29934071; PMCID: PMC6131043.

28.
The Inoculum Effect in the Era of Multidrug Resistance: Minor Differences in Inoculum Have Dramatic Effect on MIC Determination.
Smith KP, Kirby JE.
Antimicrob Agents Chemother. 2018 Jul 27;62(8):e00433-18. DOI: https://doi.org/10.1128/AAC.00433-18       
PMID: 29784837; PMCID: PMC6105823.

29.
Efficacy of Apramycin against Multidrug-Resistant Acinetobacter baumannii in the Murine Neutropenic Thigh Model.
Kang AD, Smith KP, Berg AH, Truelson KA, Eliopoulos GM, McCoy C, Kirby JE.
Antimicrob Agents Chemother. 2018 Mar 27;62(4):e02585-17. DOI: https://doi.org/10.1128/AAC.02585-17       
PMID: 29339396; PMCID: PMC5913965.

30.
Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology.
Brennan-Krohn T, Truelson KA, Smith KP, Kirby JE.
J Antimicrob Chemother. 2017 Oct 1;72(10):2775-2781. DOI: https://doi.org/10.1093/jac/dkx241        .
PMID: 29091221; PMCID: PMC5890738.

31.
Invitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
Kang AD, Smith KP, Eliopoulos GM, Berg AH, McCoy C, Kirby JE.
Diagn Microbiol Infect Dis. 2017 Jun;88(2):188-191. DOI: https://doi.org/10.1016/j.diagmicrobio.2017.03.006       
Epub 2017 Mar 16. PMID: 28341099.

32.
“Direct Detection of Intact Klebsiella Pneumoniae Carbapenemase Variants from Cell Lysates: Identification, Characterization and Clinical Implications”.
McGee, W. M., Faron, M. L., Neil, J. R., Kronewitter, S. R., Buchan, B. W., Stephenson, J. L., and Ledeboer, N. A.
Clinical Mass Spectrometry. 2020 Jul 28. DOI: https://doi.org/10.1016/j.clinms.2020.07.001       

33.
A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii.
Luna, B., Trebosc, V., Lee, B. et al.
Nat Microbiol 5, 1134–1143 (2020). DOI: https://doi.org/10.1038/s41564-020-0737-6       

34.
Comparative Evaluations of the Pathogenesis of Candida auris Phenotypes and Candida albicans Using Clinically Relevant Murine Models of Infections.
Taissa Vila, Daniel Montelongo-Jauregui, Hussian Ahmed, Taanya Puthran, Ahmed S. Sultan, Mary Ann Jabra-Rizk. Aaron P. Mitchell, Editor.
DOI: https://doi.org/10.1128/mSphere.00760-20       

35.
Micafungin and amphotericin B synergy against Candida auris. The Lancet: Microbe. Vol 1, Issue 8, E314-E315(2020).
Siddharth Jaggavarapu, Eileen M Burd, David S Weiss.
DOI: https://doi.org/10.1016/S2666-5247(20)30194-4       

36.
In Vitro Antifungal Susceptibility of the Emerging Multidrug-Resistant Pathogen Candida auris to Miltefosine Alone and in Combination with Amphotericin B.”
Wu, Yongqin et al.
Antimicrobial agents and chemotherapy vol. 64,2 e02063-19. 27 Jan. 2020, DOI: https://doi.org/10.1128/AAC.02063-19       

37.
“A Potent Host Defense Peptide Triggers DNA Damage and Is Active against Multidrug-Resistant Gram-Negative Pathogens.” Juliano, Samuel A.
ACS Publications, American Chemical Society, 6 Apr. 2020, DOI: https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.0c00051       

38.
"In Vitro Activity of Imipenem-Relebactam Alone or in Combination with Amikacin or Colistin against Pseudomonas aeruginosa". Asempa, T. E., Nicolau, D. P., & Kuti, J. L. 2020.
Antimicrobial Agents and Chemotherapy, 64(5), DOI: https://doi.org/10.1128/AAC.00467-20       

39.
Feasibility and potential significance of rapid in vitro qualitative phenotypic antimicrobial susceptibility testing of gram-negative bacilli with the ProMax system.
Chen J, Tomasek M, Cruz A, Faron ML, Liu D, et al. 2021.
PLOS ONE 16(3): e0249203. DOI: https://doi.org/10.1371/journal.pone.0249203       

Top of Page

Page last reviewed: December 14, 2021
TOP